| Literature DB >> 34036417 |
Ellen Pattison1, Alexandra Ure2,3,4,5, Sharon R Mittiga6, Katrina Williams2,3,4,7, Nerelie C Freeman6.
Abstract
This review aimed to assess the quality and content of recommendations for delivering an autism diagnosis, published internationally within clinical practice guidelines. Seventeen relevant guidelines were identified. When methodological information was provided, recommendations for feedback were predominantly formed through consensus. Recommendations consistently included who should attend feedback, the timing and mode of delivery, the clinician's manner, and what should be discussed and/or included in an accompanying report. Specific recommendations were not consistent however, and a number of gaps were identified, such as the inclusion of educators and educational specific recommendations. Although individual variation is necessary for autism diagnosis disclosure, agreement on minimum standards of practice is warranted. Further investigation is required to establish best practice.Entities:
Keywords: Assessment; Autism; Diagnosis disclosure; Feedback; Guidelines
Mesh:
Year: 2021 PMID: 34036417 PMCID: PMC8148412 DOI: 10.1007/s10803-021-05067-9
Source DB: PubMed Journal: J Autism Dev Disord ISSN: 0162-3257
Inclusion and exclusion criteria
| Inclusion criteria |
| Guidance documents that provided recommendations for clinicians (including paediatricians, general practitioners, psychologists, psychiatrists, and speech pathologists) regarding the assessment and diagnosis of autism in children under the age of 18 years |
| Guidelines published by government organisations, agencies commissioned by state or national governments and reputable national professional associations |
| Exclusion criteria |
| Documents that solely related to screening, treatment, prognosis or support services for autism |
| Guidelines for assessing autism in adult populations only |
| Guidelines not published in English |
| Guidance documents preceded by more recent editions published by the same organisation |
| Summaries of other guidelines |
| Guidelines for autism assessments for school funding/support (not medical diagnosis) |
Fig. 1Guideline selection process
Guidelines included for content analysis
| Title | Year | Publisher |
|---|---|---|
| People with Autism Spectrum Disorder: Identification, Understanding, Intervention | 2019 | Autism Europe (AE; Barthélémy et al., |
| Standards of Diagnostic Assessment for Autism Spectrum Disorder | 2019 | Canadian Paediatric Society (CPS; Brian, Zwaigenbaum & Ip, |
| A National Guideline for the Assessment and Diagnosis of Autism Spectrum Disorders in Australia | 2018 | Cooperative Research Centre for Living with Autism (CRC; Whitehouse et al., |
| Autism Spectrum Disorder—Warning signs, Detection, Diagnosis and Assessment in Children and adolescents | 2018 | Haute Autoritè De Santè (HAS; |
| Autism Spectrum Disorder under 19 s: Recognition, referral and diagnosis | 2017 | National Institute for Health and Care Excellence (NICE; |
| Clinical Practice Guideline on Assessment and Intervention Services for Young Children (Age 0–3) with Autism Spectrum Disorder | 2017 | New York State Department of Health and Bureau of Early Intervention (NY; |
| New Zealand Autism Spectrum Disorder Guideline | 2016 | Ministries of Health and Education ( |
| Assessment, Diagnosis, and Interventions for Autism Spectrum Disorders | 2016 | Scottish Intercollegiate Guidelines Network (SIGN; |
| Practice Parameter for the Assessment and Treatment of Children and Adolescents with Autism Spectrum Disorder | 2014 | American Academy of Child and Adolescent Psychiatry (AACAP; Volkmar et al., |
| Connecticut Guidelines for a Clinical Diagnosis of Autism Spectrum Disorder | 2013 | University of Connecticut School of Medicine and Dentistry (UC; |
| Autism Spectrum Disorders in Pre-School Children: AMD-MOH Clinical Practice Guidelines | 2010 | Academy of Medicine Singapore (AMS-MOH; |
| Best Practice Guidelines for the Assessment and Diagnosis of Autistic Spectrum Disorders for Children and Adolescents (birth to 18 years) | 2010 | The Psychological Society of Ireland (Autism Spectrum Disorders Special Interest Group [PSI], |
| Autism Spectrum Disorders: Missouri Best Practice Guidelines for Screening, Diagnosis, and Assessment | 2010 | Thompson Foundation for Autism and the Division of Developmental Disabilities, Missouri Department of Mental Health (MDMH; |
| Identification and Evaluation of Children with Autism Spectrum Disorders | 2007 | American Academy of Pediatrics (AAP; Johnson & Myers, |
| National Autism Plan for Children | 2003 | The National Autistic Society for National Initiative for Autism: Screening and Assessment (NAS; |
| Autism Spectrum Disorders: Best Practice for Screening, Diagnosis and Assessment | 2002 | California Department of Developmental Services (CDDS; |
| Practice Parameter: Screening and Diagnosis of Autism | 2000 | American Academy of Neurology (AAN; Filipek et al., |
A more detailed version of this table can be found in Online Resource 2
Quality analysis: summary of AGREE II domain scores, guideline ranking and overall recommendation
| Guideline (year) | Domain 1: scope and purpose | Domain 2: stakeholder involvement | Domain 3: rigor of development | Domain 4: clarity of presentation | Domain 5: applicability | Domain 6: editorial independence | Overall guideline assessment | Recommendation |
|---|---|---|---|---|---|---|---|---|
| CRC (2018) | 94 | 100 | 98 | 94 | 92 | 100 | Strongly recommend | |
| NICE ( | 100 | 100 | 98 | 97 | 85 | 92 | Strongly recommend | |
| SIGN ( | 94 | 86 | 85 | 94 | 73 | 100 | Strongly recommend | |
| NZ (2016) | 97 | 97 | 92 | 97 | 50 | 71 | Strongly recommend | |
| NY ( | 86 | 86 | 76 | 83 | 23 | 79 | Strongly recommend | |
| HAS ( | 97 | 92 | 57 | 81 | 35 | 67 | Strongly recommend | |
| CPS (2019) | 47 | 50 | 18 | 67 | 15 | 100 | Recommend with alterations | |
| UC ( | 72 | 78 | 28 | 67 | 23 | 25 | Recommend with alterations | |
| MDMH ( | 67 | 89 | 20 | 64 | 40 | 8 | Recommend with alterations | |
| NAS ( | 61 | 67 | 22 | 53 | 38 | 25 | Recommend with alterations | |
| AAN (2000) | 56 | 39 | 46 | 47 | 13 | 54 | Recommend with alterations | |
| AMS-MOH ( | 58 | 53 | 30 | 75 | 21 | 8 | Recommend with alterations | |
| AAP (2007) | 33 | 31 | 13 | 64 | 42 | 33 | Recommend with alterations | |
| AACAP (2014) | 33 | 33 | 35 | 75 | 2 | 25 | Recommend with alterations | |
| AE (2019) | 28 | 36 | 11 | 28 | 13 | 83 | Do not recommend | |
| CDDS ( | 53 | 50 | 10 | 61 | 21 | 0 | Do not recommend | |
| PSI (2010) | 69 | 33 | 10 | 53 | 2 | 4 | Do not recommend |
Bold values represent the overall guideline assessment score
Guidelines are displayed in descending order of their total average domain score. Strongly recommend = at least four of six domain scores were greater than 60%. Recommend with alterations = at least four of six domain scores were between 30 and 60%, or at least two domain scores were more than 60%. Do not recommend = if four or more domain scores were less than 30%
details of feedback recommendations and evidence reported in each guideline
| Guideline | Feedback section title (page numbers) | Level of evidence used to form feedback recommendations |
|---|---|---|
| CRC (2018) | Sharing Findings (pp. 47–48) | Grade 1a—“Body of evidence is consistent across numerous evidence sources, and there is excellent support from experts for recommendation(s)” (Whitehouse et al., |
| NICE ( | Communicating Diagnosis to the Family (pp. 120–130) | “Nine studies were included in the review. The evidence identified was qualitative, based on small scale studies, all from the UK. It reported the views of parents only and the quality was very low” |
| SIGN ( | Provision of Information (pp. 42–43) | “Recommended best practice based on the clinical experience of the guideline development group.” “A limited amount of evidence was identified” |
| NZ (2016) | Formulation, disclosure of diagnosis and post-diagnosis support (p. 54–55) | Grade B—“The recommendation is supported by FAIR evidence (based on studies that are mostly valid, but there are some concerns about the volume, consistency, applicability and/or clinical relevance of the evidence that may cause some uncertainty, but are not likely to be overturned by other evidence).” (p. 7) Grade C—“The recommendation is supported by EXPERT OPINION only (from external opinion, published or unpublished, eg, consensus guidelines).” Good Practice Points – “Where no evidence is available, best practice recommendations are made based on the experience of the Guideline Development teams or feedback from consultation within New Zealand. “ (p. 7) |
| NY ( | Engaging Families as Partners in Diagnostic Assessment and Evaluation (pp. 47–50) | Based on the opinion of panel members about current best practices |
| HAS ( | Announcement of the Medical Diagnosis and Information for Families (pp. 23–24) | Not provided |
| CPS (2019) | Communicating ASD Diagnostic Assessment Findings (pp. 448–449) | Not provided |
| UC ( | Evaluation Results (pp. 46–51) | Not provided |
| MDMH ( | Formulating Conclusions and Presenting Information (pp. 75–76) | Not provided |
| NAS ( | Outcome of the ASD Assessment Process (pp. 38–40) | Not provided |
| CDDS ( | Formulation, Presentation and Documentation of Findings (pp. 71–75) | Not provided |
| PSI (2010) | Feedback to Parents (pp. 19–21) | Not provided |
aThe CRC (2018) guideline modified the National Health and Medical Research Council approach to grading recommendations “Due to a paucity of high-level evidence identified through the systematic literature review, this modified approach allowed supporting evidence from community consultation activities and international guidelines to be reviewed alongside the research evidence from peer-reviewed journals” (Whitehouse et al., 2018)
Summary of guideline recommendations regarding how autism assessment feedback should be conducted
| Content of guideline recommendations regarding feedback | CRC (2018) | NICE ( | SIGN ( | NZ (2016) | NY ( | HAS ( | CPS (2019) | UC ( | MDMH ( | NAS ( | CDDS ( | PSI (2010) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Who should be present | The clinician/s | x | x | x | x | x | x | ||||||
| The parent/s and/or caregiver/s | x | x | x | x | x | x | x | x | x | ||||
| The child | x | x | x | x | x | x | x | ||||||
| A support person | x | x | |||||||||||
| Educator/s or other professionals | x | x | x | ||||||||||
| Timing | When should feedback occur | x | x | x | x | x | x | ||||||
| A follow up session | x | x | x | x | x | x | x | x | |||||
| Mode of delivery | Face-to-face | x | x | x | |||||||||
| Telehealth as on option for feedback | x | x | |||||||||||
| Special considerations | Families who speak English as a second language | x | x | x | x | ||||||||
| Cultural considerations | x | x | x | x | x | ||||||||
| Carers with a disability | x | x | x | x | |||||||||
| Manner of the clinician | Communication style | x | x | x | x | x | x | x | x | x | x | x | |
| Encourage questions | x | x | x | x | x | x | x | x | x | ||||
| Actively check for understanding | x | x | x | x | |||||||||
| Use visuals to aid explanation | x | ||||||||||||
| Written report | Provision of a written report | x | x | x | x | x | x | x | x | x | x | ||
| When should the report be provided | x | x | x | ||||||||||
| Who else should receive the information/report | x | x | x | x | x | x | |||||||
Recommendations regarding information shared at autism assessment feedback
| The guideline recommends providing information about: | CRC (2018) | NICE ( | SIGN ( | NZ (2016) | NY ( | HAS ( | CPS (2019) | UC ( | MDMH ( | NAS ( | CDDS ( | PSI (2010) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| The diagnostic process | The reason for referral | ☒ | □ | ||||||||||
| Diagnostic tools and/or clinicians who conducted evaluations | ☒ | × | ☒ | □ | ☒ | × | × | ||||||
| The diagnostic criteria utilised (e.g. DSM and ICD) | ☒ | ☒ | × | ☒ | × | □ | × | ||||||
| Diagnostic criteria met/not met (autism symptoms) | ☒ | ☒ | ☒ | □ | × | ☒ | □ | ☒ | ☒ | ||||
| A clear statement/confirmation of the diagnosis | ☒ | ☒ | ☒ | ☒ | × | □ | □ | × | |||||
| Autism | General information | × | ☒ | × | × | × | × | ||||||
| Resources | × | ☒ | × | ☒ | ☒ | × | × | ||||||
| Aetiology/causes/heritability | × | × | × | × | ☒ | ||||||||
| The child's presentation | Specify severity | ☒ | × | ☒ | |||||||||
| Testing results/functioning levels (not specified) | ☒ | × | ☒ | × | ☒ | ☒ | □ | ☒ | □ | ||||
| Intellectual ability | ☒ | □ | × | × | |||||||||
| Language ability/communication | |||||||||||||
| Adaptive functioning (self-help skills) | ☒ | × | |||||||||||
| Co-occurring conditions | ☒ | × | ☒ | × | |||||||||
| Prognosis and developmental trajectory | × | ☒ | ☒ | × | ☒ | × | × | × | × | ||||
| Identify strengths and difficulties | ☒ | □ | × | × | ☒ | ☒ | ☒ | ||||||
| Difficulties or support needs of the family/caregivers | × | × | × | ☒ | |||||||||
| Recommendations and referrals | Support services (not specified) | × | ☒ | × | |||||||||
| Interventions or professional therapeutic support | ☒ | × | × | ☒ | ☒ | ☒ | ☒ | ☒ | ☒ | ||||
| Social supports | ☒ | × | × | ☒ | × | ||||||||
| Funding options and services | ☒ | × | × | ☒ | × | ☒ | × | ||||||
| Educational supports and interventions | × | ☒ | ☒ | ☒ | |||||||||
| Environmental accommodations | ☒ | ||||||||||||
| Further or additional assessments required | ☒ | × | ☒ | □ | ☒ | ☒ | ☒ | ||||||
| How to disclose the diagnosis to the child | ☒ | × | × | ||||||||||
| How to disclose the diagnosis to others | ☒ | × | ☒ | × | |||||||||
☒ = share at feedback and in the report; × = share at feedback; □ = share in report